Quadrant Management

Vantem Global is a manufacturer specializing in a proprietary panel sheet system designed for construction applications. The company focuses on streamlining the building process by utilizing structural insulated panels to create volumetric modules in a factory setting. These modules are then transported to construction sites for final assembly. Vantem’s panels are weather-resistant, thermally efficient, and finish-ready, allowing for the rapid delivery of energy-efficient, climate-resistant homes and other structures. By enhancing the construction process, Vantem enables builders to reduce costs and financing expenses while accelerating project timelines, ultimately increasing profitability.

Wandercraft specializes in the development and sale of advanced exoskeletons that enable individuals with mobility impairments to walk independently. Its flagship product, Atalante, is the first exoskeleton designed for self-balanced walking, providing a realistic gait without the need for crutches or other aids. Since receiving CE-mark approval in 2019, Atalante has been utilized in European rehabilitation hospitals to assist with gait re-learning therapies. The company is also pursuing FDA approval for its technology. Additionally, Wandercraft is working on a more compact and agile Personal Mobility exoskeleton intended for everyday use. By integrating expertise in algorithmics, artificial intelligence, robotics, and clinical applications, Wandercraft aims to create innovative solutions that enhance the autonomy and quality of life for individuals with mobility challenges.

SyncThink Inc. is a neuro-technology company based in Palo Alto, California, specializing in eye-tracking technology for brain health assessment. Founded in 2009 by Dr. Jamshid Ghajar, the company has developed the EYE-SYNC device, a rapid, non-invasive tool designed to evaluate ocular motor impairments and vestibular dysfunction, key indicators of concussion. The EYE-SYNC assessment takes just 60 seconds and is used by various institutions, including university athletic departments and medical clinics like Stanford University and Massachusetts General Hospital. SyncThink has established partnerships with prominent research organizations, securing over $36 million in funding from the US Department of Defense for its development and research initiatives. The technology is FDA approved and supported by a robust intellectual property portfolio, including eleven issued patents. SyncThink's offerings extend beyond concussions, with potential applications in attention development, brain performance enhancement, and fatigue evaluation.

SyncThink Inc. is a neuro-technology company based in Palo Alto, California, specializing in eye-tracking technology for brain health assessment. Founded in 2009 by Dr. Jamshid Ghajar, the company has developed the EYE-SYNC device, a rapid, non-invasive tool designed to evaluate ocular motor impairments and vestibular dysfunction, key indicators of concussion. The EYE-SYNC assessment takes just 60 seconds and is used by various institutions, including university athletic departments and medical clinics like Stanford University and Massachusetts General Hospital. SyncThink has established partnerships with prominent research organizations, securing over $36 million in funding from the US Department of Defense for its development and research initiatives. The technology is FDA approved and supported by a robust intellectual property portfolio, including eleven issued patents. SyncThink's offerings extend beyond concussions, with potential applications in attention development, brain performance enhancement, and fatigue evaluation.